Diabetes Mellitus Type 2 Perspective

 
 

  • ESC 2022 DELIVERing the Details on Dapagliflozin in Heart Failure   Drs Pina and Solomon discuss the DELIVER trial presented at the European Society of Cardiology and whether all patients with heart failure should get SGLT2 inhibitors regardless of ejection fraction.
  • Time to Re-evaluate Herbal Supplements? The death of Lori McClintock is focusing attention on the use of nutritional supplements. Dr Caroline Apovian offers insight on unregulated supplements and ways clinicians can help patients.
  • Guidelines on GLP1RAs and Glucose Monitors Irl B. Hirsch, MD, reviews new guidelines for glucose monitors and inhibitors.
  • Don't Overlook NAFLD in Lean Patients Dr Nancy Reau speaks with gastroenterologist Dr Michelle Long about the challenges of identifying and treating NAFLD in patients without obesity.
  • ESC 2022 Do SGLT2 Inhibitors DELIVER in All Heart Failure? The investigators of the DELIVER trial and others suggest that all patients with heart failure get SGLT2 inhibitors, but this cardiologist sees differing effects depending on ejection fraction.
  • Earlier Is Better: Treat Patients Before Type 2 Diabetes Develops   Ralph DeFronzo, MD, discusses treating type 2 diabetes early and using drugs to correct the pathophysiologic disturbances associated with it.
  • Integrated Care and New Technologies in Type 1 Diabetes   Chantal Mathieu, MD, PhD, discusses access to care, integrated care, and new technologies in type 1 diabetes.
  • Key Abstracts in Dementia Science From AAIC 2022   Key abstracts from AAIC 2022, as reported by Dr Michael Rafii, focus on crenezumab in autosomal dominant Alzheimer's disease and AD biomarkers in diabetes, Down syndrome, and persons with poor sleep.
  • How Much Weight Does My Patient Need to Lose? Dr Donna Ryan discusses why we need to think of weight loss in terms of percentages, not pounds shed, and provides insight into how as little as a 5% loss can improve individual health.
  • Change Makers: David Ricks Is Leading With Purpose   WebMD's Chief Medical Officer, John Whyte, MD, speaks with David Ricks, chair and chief executive officer of Eli Lilly and Company, about the speed of drug development: Is it sustainable, and what do we need to make it happen?
  • Annual Heart Failure Testing in Diabetes: New Rec   All patients with diabetes are at risk and should be followed annually with one of these biomarkers.
  • Episode 2: How to Manage Chronic Kidney Disease in Primary Care   What do primary care providers need to know to improve care for people with chronic kidney disease? Drs Matthew Sparks and Ian de Boer provide key clinical takeaways that can't be ignored.
  • Episode 1: Chronic Kidney Disease and SGLT2 Inhibitors   Drs Sparks and Neuen discuss the proper use of SGLT2 inhibitors to prevent chronic kidney disease, including how to start them and monitor them and their possible side effects.
  • Get the Complete Picture by Using CGM for Those With Diabetes   Eugene Wright, MD, discusses why you should be using continuous glucose monitoring in the primary care setting for your patients with diabetes.
  • Do You Consider Medications to Treat Obesity? It's no longer acceptable to tell patients with obesity to "just try harder." Instead, Dr Robert F. Kushner counsels, it's time to consider medication for weight management.
  • Episode 1: Risks Associated With Antipsychotic Medications   Drs John Kane and Christoph U. Correll discuss the types of monitoring and support that patients with schizophrenia may need while receiving antipsychotic medications.
  • What Is the Weight Impact of Type 2 Diabetes Treatment?   Priya Sumithran, PhD, discusses the importance of weight management in patients with type 2 diabetes
  • Do Sugary Drink Taxes Change Behavior?   Many countries have implemented taxes on sugary drinks to reduce consumption. Anna Grummon, PhD, MSPH, discusses the latest research on these taxes.
  • Putting the Patient First: Top Insights From ADA 2022   From new guidelines for managing glucose to possible remission of type 2 diabetes, Dr Akshay Jain reviews what he feels are the most important studies from the ADA Scientific Sessions.
  • Let's Talk About Sex: Women With Diabetes Often Lose Interest   Many women with diabetes often lose interest or have discomfort during sex. Sharon Parish, MD, discusses these problems and solutions, and the importance of talking to patients about these issues.